You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Shire in $4.2 billion deal to buy ViroPharma

Irish firm seeks to boost its drugs for rare diseases

LONDON — The drug maker Shire PLC, seeking to strengthen its portfolio of treatments for rare diseases, said Monday that it would buy ViroPharma Inc. for about $4.2 billion in cash.

The Dublin-based drug maker would pay $50 for each share of ViroPharma, a bio-pharmaceutical company based in Exton, Pa. That represents a 27 percent premium on the company’s closing price Friday, the last trading day before the deal was announced.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week